aizon
Provides AI software to optimize pharmaceutical manufacturing processes.
Company facts
- Founded
- 2013
- Employees
- 159
- Headquarters
- United States
- CEO
- Pep Gubau
- Type
- Private
- Funding
- Series C · $20M · 2024
About
We are Aizon, and we're at the forefront of revolutionizing pharmaceutical manufacturing through the power of artificial intelligence. Our journey began with a clear mission: to empower pharmaceutical and biotech companies to transform their manufacturing operations. We achieve this by harnessing advanced analytics, AI, and other smart factory technologies to optimize production and elevate quality standards within the highly regulated landscape of the life sciences industry. Our core belief is that data is the key to a better tomorrow. We've developed a unified, GMP-compliant predictive analytics platform that stands apart due to its unique integration of intelligent batch records, a contextualized lakehouse, and a purpose-built foundation for GMP-grade AI industrialization. This allows us to seamlessly integrate vast sources of both structured and unstructured data, delivering actionable insights that span across all manufacturing sites. We empower people to solve complex problems, to understand their past performance, and to confidently shape their future operations. Our platform is designed to provide real-time visibility and predictive insights, all within a GxP compliant framework that ensures end-to-end data integrity. For over a decade, we have been delivering tangible AI-driven outcomes for our partners, such as increased yield, reduced Cost of Goods Sold (COGS), and expanded capacity. Our solutions, including Aizon Execute, Aizon Unify, and Aizon Predict, are crafted to guide our customers through their digital maturity journey. Whether it's digitizing processes, breaking down data silos, or industrializing AI, we provide the tools for success. We are not just a technology provider; we are a partner in innovation. We work alongside our customers to build what comes next, fostering a culture of continuous improvement and data-driven decision-making. By combining our cutting-edge AI capabilities with a deep understanding of the engineering and compliance challenges in the pharmaceutical world, we enable companies to accelerate innovation, optimize their manufacturing processes, and ultimately, deliver life-saving therapies to patients faster and more efficiently.